3-122540481-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001146105.2(PARP9):c.1756C>T(p.Arg586Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,612,394 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001146105.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARP9 | NM_001146105.2 | c.1756C>T | p.Arg586Cys | missense_variant | 8/11 | ENST00000682323.1 | NP_001139577.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARP9 | ENST00000682323.1 | c.1756C>T | p.Arg586Cys | missense_variant | 8/11 | NM_001146105.2 | ENSP00000507390.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152110Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251108Hom.: 0 AF XY: 0.0000811 AC XY: 11AN XY: 135718
GnomAD4 exome AF: 0.0000425 AC: 62AN: 1460284Hom.: 0 Cov.: 30 AF XY: 0.0000537 AC XY: 39AN XY: 726274
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152110Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.1861C>T (p.R621C) alteration is located in exon 8 (coding exon 7) of the PARP9 gene. This alteration results from a C to T substitution at nucleotide position 1861, causing the arginine (R) at amino acid position 621 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at